Advertisement

Ads Placeholder
Loading...

NervGen Pharma Corp.

NGENF•PNK
Healthcare
Biotechnology
$3.95
$-0.10(-2.47%)
U.S. Market opens in 5h 3m

NervGen Pharma Corp. (NGENF) Stock Technical Analysis & Trading Signals

Live technical indicators, trading signals, and momentum insights for NervGen Pharma Corp. (PNK:NGENF).

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

NGENF Technical Analysis Summary

NervGen Pharma Corp. stock currently shows a bearish trend, weighed down by selling pressure and weak momentum.

Overall Sentiment:Sell
Momentum:Bullish to Strongly Bullish (RSI: 19.46)
Trend Strength:Very Strong (ADX: 72.30)
Volatility:High (ATR: 0.40)

Technical conditions suggest NervGen Pharma Corp. is consolidating, awaiting a decisive move.

Momentum Indicators

RSI (14): 19.46

Bullish
Oversold, buying opportunity potential.

Stochastic %K: 18.49

Bullish
Oversold zone signals rebound potential.

Williams %R: -87.68

Bullish
Oversold zone suggests rebound potential.

Rate of Change (ROC): -29.62

Strongly Bearish
Sharp downside momentum.

Takeaway:NervGen Pharma Corp. shows oversold momentum, with rebound potential building.

Trend & Volatility

MACD: -0.44

Bearish
Bearish, trend momentum is strengthening to the downside.

ADX: 72.30

Very Strong
Very strong trend, powerful directional momentum.

ATR (14): 0.40

Low
Low volatility, stable price action.

CCI (14): -86.27

Bearish
Bearish, momentum remains under pressure.

Takeaway:NervGen Pharma Corp. shows weakening trend signals, with bearish pressure building.

Support & Resistance indicators
Bollinger Bands
Upper Band
-
Middle Band (SMA 20)
-
Lower Band
-
Current Position
Unknown
Keltner Channels
Upper Channel
$5.40
Middle Line (EMA 20)
$4.60
Lower Channel
$3.80
Squeeze Status
Unknown

Takeaway:NervGen Pharma Corp. trades below the trend line, showing weaker momentum inside the channel.

Volume & Money Flow Analysis
On-Balance Volume-919.61K
Money Flow Index37.55Bearish, selling pressure outweighs inflows.
Relative Vigor Index46.15Neutral to Bearish, sellers hold a slight edge.

Overall Takeaway:NGENF shows bearish money flow, with sellers dominating volume and vigor.

Technical Trading Signals Summary
Based on the current technical analysis of NervGen Pharma Corp., here are the key trading signals and recommendations:

Bullish Signals

ADX above 20 → strong underlying trend.

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

MACD below signal line → short-term caution on momentum.

RVI below 50 → vigor tilted toward sellers.

Overall Recommendation:Insufficient data to provide a recommendation for NervGen Pharma Corp..

Technical Analysis FAQ